Literature DB >> 22119452

Comparative bone status assessment by dual energy X-ray absorptiometry, peripheral quantitative computed tomography and quantitative ultrasound in adolescents and young adults with cystic fibrosis.

Jean De Schepper1, Inge Roggen, Stephanie Van Biervliet, Eddy Robberecht, Inge Gies, Kathleen De Waele, Elke De Wachter, Anne Malfroot, Frans De Baets, Kaatje Toye, Stefan Goemaere, Olivia Louis.   

Abstract

PURPOSE: Quantitative ultrasound bone sonometry (QUS) might be a promising screening method for cystic fibrosis (CF)-related bone disease, given its absence of radiation exposure, portability of the equipment and low cost.The value of axial transmission forearm QUS in detecting osteopenia in CF was therefore studied.
METHODS: We investigated the application of QUS in the evaluation of bone status in a group of 64 adolescents (>12 years) and young adults (<40 years) with CF in a comparison with a dual X-ray absorptiometry (DXA) of the whole body and peripheral quantitative computed tomography (pQCT) of the radius at 4% and 66% sites.
RESULTS: Mean (SD) Z-scores of speed of sound (SOS), whole body bone mineral content (BMC), radial trabecular bone mineral density (BMD), and radial cortical BMD were respectively -0.31 (0.78), -0.09 (1.28), 0.10 (1.16) and -0.62 (2.88). The pQCT determined bone geometry values (cortical bone area and cortical thickness) were more depressed than the BMD data. QUS had a sensitivity and specificity of respectively 0% and 96% for diagnosing osteopenia (based on a whole body BMC Z-score<-2).
CONCLUSIONS: QUS cannot replace DXA, but can screen out patients with normal bone mass. Further and larger studies are needed to examine if QUS may reflect other aspects than bone mass, or if it is possible to improve its sensitivity by supplementing the SOS results with clinical risk factors. Copyright Â
© 2011 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22119452     DOI: 10.1016/j.jcf.2011.10.004

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  6 in total

1.  Cortical and trabecular bone at the radius and tibia in male and female adolescents with Down syndrome: a peripheral quantitative computed tomography (pQCT) study.

Authors:  A González-Agüero; G Vicente-Rodríguez; A Gómez-Cabello; J A Casajús
Journal:  Osteoporos Int       Date:  2012-06-09       Impact factor: 4.507

2.  Children and adolescents with cystic fibrosis display moderate bone microarchitecture abnormalities: data from high-resolution peripheral quantitative computed tomography.

Authors:  C Braun; J Bacchetta; P Braillon; R Chapurlat; J Drai; P Reix
Journal:  Osteoporos Int       Date:  2017-08-09       Impact factor: 4.507

Review 3.  Cystic fibrosis-related bone disease: insights into a growing problem.

Authors:  Michael S Stalvey; Gregory A Clines
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2013-12       Impact factor: 3.243

4.  Percentage of body fat assessment using bioelectrical impedance analysis and dual-energy X-ray absorptiometry in a weight loss program for obese or overweight Chinese adults.

Authors:  Yi-Chun Li; Chia-Ing Li; Wen-Yuan Lin; Chiu-Shong Liu; Hua-Shui Hsu; Cheng-Chun Lee; Fei-Na Chen; Tsai-Chung Li; Cheng-Chieh Lin
Journal:  PLoS One       Date:  2013-04-01       Impact factor: 3.240

Review 5.  Peripheral quantitative computed tomography (pQCT) for the assessment of bone strength in most of bone affecting conditions in developmental age: a review.

Authors:  Stefano Stagi; Loredana Cavalli; Tiziana Cavalli; Maurizio de Martino; Maria Luisa Brandi
Journal:  Ital J Pediatr       Date:  2016-09-26       Impact factor: 2.638

6.  Evaluation of bone mineralization in former preterm born children: Phalangeal quantitative ultrasound cannot replace dual-energy X-ray absorptiometry.

Authors:  Carmen M T Lageweg; Mayke E van der Putten; Johannes B van Goudoever; Ton Feuth; Martin Gotthardt; Arno F J van Heijst; Viola Christmann
Journal:  Bone Rep       Date:  2018-01-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.